Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
Most cases of adult-onset (AO) GH deficiency (GHD) result from the presence of hypothalamo-pituitary tumors or their treatment. GH replacement is now widely used in adults with hypopituitarism, but its effect on hypothalamo-pituitary tumor growth or recurrence is unknown. Anecdotal evidence from ear...
Prif Awduron: | Frajese, G, Drake, WM, Loureiro, R, Evanson, J, Coyte, D, Wood, D, Grossman, AB, Besser, G, Monson, J |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2001
|
Eitemau Tebyg
-
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
gan: Chung, T, et al.
Cyhoeddwyd: (2008) -
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
gan: Drake, WM, et al.
Cyhoeddwyd: (1998) -
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
gan: Kaltsas, G, et al.
Cyhoeddwyd: (2000) -
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
gan: Chung, T, et al.
Cyhoeddwyd: (2005) -
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
gan: Agha, A, et al.
Cyhoeddwyd: (2007)